+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

HIV/AIDS Drugs Market Research Reports

Fusion Inhibitors Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024-2032 - Product Thumbnail Image

Fusion Inhibitors Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024-2032

  • Report
  • March 2024
  • 118 Pages
  • Global
From
Integrase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Integrase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Fusion Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Fusion Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
HIV Attachment Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

HIV Attachment Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Exportin-1 protein inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Exportin-1 protein inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
HIV integrase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

HIV integrase inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Human Immunodeficiency Virus Type-1 (HIV-1) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Human Immunodeficiency Virus Type-1 (HIV-1) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
HIV-associated Lipodystrophy - Epidemiology Forecast to 2032 - Product Thumbnail Image

HIV-associated Lipodystrophy - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Human Immunodeficiency Virus Type 1 (HIV-1) Infection - Epidemiology Forecast - 2032 - Product Thumbnail Image

Human Immunodeficiency Virus Type 1 (HIV-1) Infection - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HIV (Human Immunodeficiency Virus) - Epidemiology Forecast - 2032 - Product Thumbnail Image

HIV (Human Immunodeficiency Virus) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HIV Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

HIV Drugs Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
HIV Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

HIV Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Anti-Retroviral Drugs Market - Growth, Trends, COVID-19 and Forecasts (2023-2028) - Product Thumbnail Image

Anti-Retroviral Drugs Market - Growth, Trends, COVID-19 and Forecasts (2023-2028)

  • Report
  • April 2023
  • 110 Pages
  • Global
From
Prophylactic HIV Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Prophylactic HIV Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 110 Pages
  • Global
From
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies - Product Thumbnail Image

HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

  • Report
  • December 2023
  • 109 Pages
  • Global
From
HIV Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

HIV Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • January 2024
  • 150 Pages
  • Global
From
India Lopinavir & Ritonavir Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Thumbnail Image

India Lopinavir & Ritonavir Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • December 2024
  • 85 Pages
  • India
From
HIV-associated Lipodystrophy Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Thumbnail Image

HIV-associated Lipodystrophy Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • October 2023
  • 190 Pages
  • Global
From
United States Pre-Exposure Prophylaxis (PrEP) Market, Competition, Forecast and Opportunities, 2018-2028 - Product Thumbnail Image

United States Pre-Exposure Prophylaxis (PrEP) Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • October 2023
  • 78 Pages
  • United States
From
Maraviroc Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Maraviroc Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 73 Pages
  • Global
From
Loading Indicator

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus. The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more